Short description
Avraham Pharmaceuticals, a pharmaceutical company, develops novel products for the treatment and prevention of neurodegenerative disorders.
Description
Avraham Pharmaceuticals (“Avraham”) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer's disease, supporting the development of its lead product candidate, ladostigil.
Total funding
$$2020202
Sign in for full access
Location
Yavneh, HaMerkaz, Israel, Asia
Founded on
January 1, 2010
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Absolutely Noaccess, No Way, Blurry Noaccess, Absolutely Noaccess
Sign in for full access
Founders
Marta Weinstock-Rosin, Michael Chorev, Moussa Youdim